Xxxxxxx Activities. Neither the Buyer nor its affiliates has an open short position in the common stock of the Company and the Buyer agrees that it shall not, and that it will cause its affiliates not to, engage in any short sales of or hedging transactions with respect to the common stock of the Company.
Xxxxxxx Activities. One of the objectives of the Project shall be for Abbott to develop and manufacture Bulk Drug Substance and to support ZymoGenetics’ Regulatory Filings as appropriate, however, ZymoGenetics shall be responsible forthe preparation and filing of Regulatory filings, and all communications with Regulatory Authorities, with respect to the Bulk Drug Substance. Abbott shall conduct and perform according to the work-plan set forth in Exhibit C as may be amended from time to time by the Parties to achieve such objectives, including, but not limited to, the following:
a. Sourcing raw materials for use in manufacturing Bulk Drug Substance, with the price of such materials included in the price of the Project, excluding the [ * ]
b. Performing pilot scale evaluation of ZymoGenetics’ manufacturing process;
c. Adapting ZymoGenetics’ manufacturing process to Xxxxxx’x equipment and systems. In no event, without ZymoGenetics’ prior written approval and the Parties’ written agreement on licensing terms, xxxx Xxxxxx incorporate any proprietary procedures or processes (whether or not patented and including, without limitation, any Abbott Invention) into the manufacturing process that [ * ] designated portions of this document have been omitted pursuant to a request for confidential treatment filed separately with the Commission. would require ZymoGenetics’ to obtain a license (from Abbott or any Third Party) in order to practice such manufacture of any Bulk Drug Substance. In the event Abbott incorporates any such proprietary procedures or processes without first obtaining ZymoGenetics’ written consent, Abbott hereby grants to ZymoGenetics a royalty-free, irrevocable, worldwide, nonexclusive license (or sublicense, if applicable) (with the right to sublicense) to practice the proprietary procedures or processes;
d. Developing [ * ] to manufacture Bulk Drug Substance in Xxxxxx’x manufacturing facility;
e. Preparing suitable manufacturing process documentation, including instructions and manufacturing controls for inclusion in Regulatory Filings;
f. Provide the Bulk Drug Substance information directly to ZymoGenetics in support of Regulatory Filings, and assisting ZymoGenetics in responding to questions from Regulatory Authorities concerning the manufacture of Bulk Drug Substance;
g. Conducting material contact and cleaning validation studies, engineering and validation runs, process validation studies, and preparing process justification and validation summary reports, in a mu...
Xxxxxxx Activities. The Union shall appoint or elect stewards and shall notify the University in writing of such appointment or election. The University shall recognize stewards and shall not discriminate against them for xxxxxxx activity. The Union and the University shall agree as to the on-the-job activities of the stewards. Those activities as defined shall be:
(a) the posting of union bulletins and notices;
(b) the investigation of and the processing of grievances;
(c) the supervision of ballot boxes when necessary;
(d) carrying out those duties within the realm of safety responsibilities.
Xxxxxxx Activities. One of the objectives of the Project shall be for Abbott to develop and manufacture Bulk Drug Substance and to support Seattle Genetics’ Regulatory Filings as appropriate, however, Seattle Genetics shall be responsible for the preparation and filing of Regulatory Filings, and all communications with Regulatory Authorities, with respect to the Bulk Drug Substance. Abbott shall conduct and perform its obligations on the work-plan set forth in Exhibit C as may be amended from time to time by mutual agreement of the Parties to achieve such objectives, including, but not limited to, the following:
a. Sourcing raw materials for use in manufacturing Bulk Drug Substance, with the price of such materials excluded from the price of the Project up to commercial production
b. Performing pilot scale evaluation of Seattle Genetics’ manufacturing process;
c. Adapting Seattle Genetics’ manufacturing process to Xxxxxx’x equipment and systems;
d. Developing optimized process parameters to manufacture Bulk Drug Substance in Xxxxxx’x manufacturing facility;
e. Preparing suitable manufacturing process documentation, including instructions and manufacturing controls for inclusion in Regulatory Filings;
f. Provide the Bulk Drug Substance information directly to Seattle Genetics in support of Regulatory Filings, and assisting Seattle Genetics in responding to questions from Regulatory Authorities concerning the manufacture of Bulk Drug Substance;
g. Conducting material contact and cleaning validation studies, engineering and validation runs, process validation studies, and preparing process justification and validation summary reports, in a mutually agreed upon timely manner, to meet pre-approval and other appropriate inspection requirements of the Regulatory Authorities and to support approval of the manufacture of the Bulk Drug Substance in an Abbott manufacturing facility;
h. Permitting Seattle Genetics to conduct all necessary cGMP and quality assurance reviews of Abbott documentation, including review and receipt of copies of Abbott manufacturing work orders;
i. Permitting Seattle Genetics to access Xxxxxx’x manufacturing data relating to Bulk Drug Substance;
j. Providing Seattle Genetics with acceptable environmental impact statements, if required, for inclusion with Regulatory Filings;
k. Providing Seattle Genetics with appropriate pilot and commercial scale batch record manufacturing documentation for Regulatory Filings and other uses in accordance with the Quality Agreem...
Xxxxxxx Activities. The Company will pay up to a maximum of twenty (20) hours in wages per week for time spent administering the collective bargaining agreement (CBA). It is understood that this time will be limited to activities outlined within Article V, Section 1 of the CBA. The Union Business Representative will identify a designee that may authorize utilization of time against this allocation. Employees must obtain permission from both the designee and the Labor Relations Manager prior to utilizing time against this allocation. It is further understood that time associated with Union business beyond the allocation of twenty (20) hours shall not be the burden of the Company. Union Activities Paid (UAP) will count toward time worked in the computation of overtime.
Xxxxxxx Activities. The Investor's trading activities with respect to the Company's Common Stock have been and shall be in compliance with all applicable federal and state securities laws, rules and regulations and the rules and regulations of the Principal Market on which the Company's Common Stock is listed or traded. Neither the Investor nor its affiliates has an open short position in the Common Stock of the Company, the Investor agrees that it shall not, and that it will cause its affiliates not to, engage in any short sales of or hedging transactions with respect to the Common Stock, provided that the Company acknowledges and agrees that upon receipt of an Advance Notice the Investor is permitted to sell the shares to be issued to the Investor pursuant to the Advance Notice during the applicable Pricing Period.
Xxxxxxx Activities. The Union acknowledges that Stewards have their regular duties to perform on behalf of the Employer and that such persons shall not leave their regular duties without having first secured permission from their immediate Supervisor, which permission shall not be unreasonable withheld. Stewards shall state their destination to their immediate Supervisor and shall report again to him at the time of their return to work. The Employer reserves the right at any time to limit or withdraw t he permission to process grievances during working hours if at any time this privilege is being abused or if it unduly interferes with the operations of the Employer. If a Union Xxxxxxx is requested by the Company they will be paid for their time.
Xxxxxxx Activities. The Union acknowledges that Stewards have their regular duties to on behalf of the Employer and that such persons shall not leave their regular duties without having first secured from their immediate Supetvisor, which shall not be unreasonable Stewards shall state their destination to their immediate Supervisor and report to him at the time of their return to work. The Employer reservesthe a: time to limit or t he permission to process grievances during working hours if at any time this privilege is being abused or if it unduly interferes with the operations of the Employer. If a Union Xxxxxxx is requested by the Company they will be paid for their time. Union Xxxxxxx Appointments The Employer acknowledges the right of the Union to appoint or otherwise select stewards who have completed their period of employment. There shall be no than (4) appointed Stewards at any time and no more than one Xxxxxxx in each department.
Xxxxxxx Activities. The Company acknowledges and agrees that Xxxxxxx has disclosed certain business activities and projects to the Company’s CEO (the “Xxxxxxx Activities”). Xxxxxxx represents and warrants to the Company that in connection with the Xxxxxxx Activities, Xxxxxxx has not violated Section 1.5 or Section 1.8(b) of the Previous Employment Agreement. The Company further agrees that, as long as Xxxxxxx continues to comply with Sections 1.5 and 1.8(b) of the Previous Employment Agreement, the Xxxxxxx Activities shall not be in violation of Xxxxxxx’x obligations under Section 1.8(a) of the Previous Employment Agreement.
Xxxxxxx Activities. The routine activities performed in accordance with this MOU are the responsibility of the DOE Operations Office in coordination with the NRC program or regional office. Therefore, every attempt should be made to resolve , operational problems at tha field level. When possible, a problem should be I identified in writing. If a problem cannot be resolved at the field level, the matter will be raised through each agency's management chain, as necessary and appropriate. |
